Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report

Shawnalyn W. Sunagawa, Joshua P. Havens, Anthony Podany, Bryan Walker, Kimberly K. Scarsi, Sara H. Bares

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

As antiretroviral therapy advancements focus on long-acting medications, there is a need to assess the potential impact of drug–drug interactions. We present a real-world case of long-acting cabotegravir/rilpivirine co-administered with intravenous rifampin.

Original languageEnglish (US)
Article numberofad604
JournalOpen Forum Infectious Diseases
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2023

Keywords

  • drug-drug interactions
  • long-acting cabotegravir/ rilpivirine
  • plasma concentrations
  • rifamycins

ASJC Scopus subject areas

  • Oncology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report'. Together they form a unique fingerprint.

Cite this